(University of Michigan) Most of the roughly 15.5 million cancer survivors in the US receive chemotherapy, and roughly 65 percent develop some degree of the chemotherapy-induced nerve damage known as peripheral neuropathy.
More From BioPortfolio on "Diagnosing, treating neuropathy symptoms in cancer patients not exact science"